Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

Clinical trial NCT00241553 · COMPLETED

Trial details

NCT number: NCT00241553
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

NSAIDs Upper GI Symptoms

Start date: 2001-04-01
Primary completion: 2003-02-01
Enrollment: 276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.